Shilpa Medicare gets initial authorization from EMA for Rivaroxaban Orodispersible Films
- 23 September 2025
- 1 month ago
Extending Rivaroxaban Treatment After Distal DVT Reduces Further Clot Risk
- 01 August 2025
- 3 months ago
Recent News
HC pulls up NMC for not filing reply in FMG Intern...
- 04 November, 2025
Eli Lilly plans to build new USD 3 billion facilit...
- 04 November, 2025
Rajkot Maternity Hospital CCTV Leak: How a simple...
- 04 November, 2025
Gland Pharma profit rises 12 percent to Rs 184 cro...
- 04 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.


